Global Colon Cancer Association shared a post on LinkedIn:
“July 29, 2026 | 11:00 AM EDT (15:00 UTC)
How can advocates help patients access the right testing, treatment options, and clinical trials?
Join the Global Colon Cancer Association for HER2 and Colorectal Cancer: What Advocates Need to Know, a webinar designed to equip advocates with practical knowledge about HER2-positive colorectal cancer and the role biomarker testing can play in guiding care.
We’re honored to be joined by:
- John Strickler, MD, Duke University, Co-Leader of the Precision Cancer Medicine and Investigational Therapeutics Program, Leader of the Molecular Tumor Board, and Associate Director of Clinical Research – GI Oncology
- Elle Charnisky, colorectal cancer advocate and participant in the MOUNTAINEER clinical trial
Moderated by Nicole Sheahan, President of the Global Colon Cancer Association.
Attendees will learn:
- What HER2 is and its role in colorectal cancer
- Why biomarker testing matters
- How advocates can support patients in accessing biomarker testing
- How biomarker results may help identify clinical trial opportunities
- The patient perspective on navigating precision medicine
Register now.
Thank you to Pfizer for supporting this educational program.”
Other articles from Global Colon Cancer Association on OncoDaily.